| Stereochemistry | MIXED |
| Molecular Formula | C33H40I6N6O15 |
| Molecular Weight | 1522.1287 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OCC(O)CNC(=O)C1=C(I)C(C(=O)NCC(O)CO)=C(I)C(N(CC(O)CN(C=O)C2=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C2I)C=O)=C1I
InChI
InChIKey=BFVVDRUCXCIALU-UHFFFAOYSA-N
InChI=1S/C33H40I6N6O15/c34-22-18(30(57)40-1-13(52)7-46)24(36)28(25(37)19(22)31(58)41-2-14(53)8-47)44(11-50)5-17(56)6-45(12-51)29-26(38)20(32(59)42-3-15(54)9-48)23(35)21(27(29)39)33(60)43-4-16(55)10-49/h11-17,46-49,52-56H,1-10H2,(H,40,57)(H,41,58)(H,42,59)(H,43,60)
| Molecular Formula | C33H40I6N6O15 |
| Molecular Weight | 1522.1287 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Ioforminol is a triiodobenzenedicarboxamide derivative patented by Ge Healthcare A/S as diagnostic agent for X-ray imaging. The toxicity and biodistribution properties of Ioforminol are similar to those of other radiographic contrast media. However, the osmolality of Ioforminol solutions is considerably lower than that of other dimeric radiographic contrast media, thus allowing for an iso-osmolar formulation containing a high concentration of electrolytes. Ioforminol has been used in trials studying the diagnostic of Cardio Renal Safety in High-risk Elderly Subjects Undergoing a Coronary CATH
